SNT 0.00% 3.9¢ syntara limited

Ann: Change in substantial holding from Arix Bioscience, page-9

  1. 2,661 Posts.
    lightbulb Created with Sketch. 89
    This is of interest

    "An FDA approval would also provide an opportunity to investigate different ways of structuring the Pharmaxis business and funding our drug development activities.”"

    Could they go down the track of becoming a generic drug manufacturer. From memory PXS have FDA compliance at their premises.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.000(0.00%)
Mkt cap ! $44.17M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $66.77K 1.752M

Buyers (Bids)

No. Vol. Price($)
1 493 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 209403 1
View Market Depth
Last trade - 14.38pm 24/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.